Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 2Terminated 1No longer available 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2NET 1

Conditions

Carcinoid Tumor 2Pinealoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Meningioma 1Medulloblastoma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Familial ependymoma 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

gallium Ga 68 dotatate 2veliparib 1telotristat ethyl 1Temozolomide 1Panitumumab 1Octreotide 1Capecitabine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Carcinoid Tumor × gallium Ga 68 dotatate × Clear all
NCT03623984 2023-09-11

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

University of Alabama at Birmingham

Phase EARLY_PHASE1 Withdrawn
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT03057509 2019-06-21

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Massachusetts General Hospital

Phase 1 Withdrawn
Endocrine

Carcinoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡